Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.39 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.39 |
| ▸ | DHFR | P00374 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
| ▸ | ALPL | P05186 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29410295 | 1.00 | ALDH1A1 (0.41) | ALDH1A1CYP2A6CYP1A2ALOX5KDM4E | |
| SCHEMBL30390526 | 1.00 | ALDH1A1 (0.41) | ALDH1A1CYP2A6CYP1A2ALOX5KDM4E | |
| SCHEMBL29634684 | 0.92 | ALDH1A1 (0.41) | ALDH1A1CYP2A6CYP1A2ALOX5KDM4E | |
| SCHEMBL26813563 | 0.86 | AKR1C3 (0.41) | ALDH1A1CYP2A6CYP1A2ALOX5KDM4E | |
| SCHEMBL29952492 | 0.86 | AKR1C3 (0.41) | ALDH1A1CYP2A6CYP1A2ALOX5KDM4E | |
| Boric Acid SCHEMBL28565435 | 0.84 | CYP1A2 (0.50) | ALDH1A1CYP2A6CYP1A2ALOX5KDM4E | |
| SCHEMBL29391558 | 0.82 | ALDH1A1 (0.48) | ALDH1A1CYP2A6CYP1A2HPGDTSHR | |
| SCHEMBL24488 | 0.82 | ALDH1A1 (0.48) | ALDH1A1CYP2A6CYP1A2HPGDTSHR | |
| SCHEMBL5601608 | 0.82 | ALDH1A1 (0.48) | ALDH1A1CYP2A6CYP1A2HPGDTSHR | |
| SCHEMBL910658 | 0.82 | ENPP2 (0.50) | MAPTENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115959993-A | Synthetic method of 2-aryl propionic acid compound | 山东中医药大学 | 2023-04-14 | — | — | CN | claimed |
| CN-110376320-B | Method for full-automatic series solid-phase extraction of brassinosteroids in plants | 中国科学院大连化学物理研究所 | 2021-04-27 | — | — | CN | claimed |
| CN-115959993-B | Synthesis method of 2-aryl propionic acid compound | 山东中医药大学 | 2025-01-07 | — | — | CN | disclosed |
| CN-117720447-A | Method for synthesizing 1,3-N, S compound by rhodium catalysis | 华南理工大学 | 2024-03-19 | — | — | CN | disclosed |
| US-20240090327-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2024-03-14 | — | — | US | disclosed |
| US-11891361-B2 | Heterocyclic compound and organic light emitting device comprising same | LT MATERIALS CO., LTD. (KR) | 2024-02-06 | — | — | US | disclosed |
| CN-117225436-A | CdS/Bi/Ti 3 C 2 T X Photocatalyst, preparation method and application thereof | 华南理工大学 | 2023-12-15 | — | — | CN | disclosed |
| CN-114733566-B | Chiral super-strong carbonic acid catalyst based on BINOL framework and preparation method and application thereof | 上海师范大学 | 2023-10-31 | — | — | CN | disclosed |
| US-20230242484-A1 | NITROGEN-CONTAINING COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC APPARATUS USING SAME | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-08-03 | — | — | US | disclosed |
| US-20230242484-A1 | NITROGEN-CONTAINING COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC APPARATUS USING SAME | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-08-03 | — | — | US | disclosed |
| EP-4200294-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | Merck Patent GmbH (DE) | 2023-06-28 | — | — | EP | disclosed |
| US-20110095273-A1 | DEUTERATED COMPOUNDS FOR LUMINESCENT APPLICATIONS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-04-28 | — | — | US | disclosed |
| WO-2011040939-A1 | DEUTERATED COMPOUNDS FOR LUMINESCENT APPLICATIONS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-04-07 | — | — | WO | disclosed |
| US-20110049477-A1 | ELECTROACTIVE MATERIALS | E I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-03-03 | — | — | US | disclosed |
| US-20100297035-A1 | Thiazole Amides, Imidazole Amides and Related Analogues | LIGAND PHARMACEUTICALS, INC. (US) | 2010-11-25 | — | — | US | disclosed |
| US-7728009-B1 | Thiazole amides, imidazole amides and related analogues | NEUROGEN CORPORATION (US) | 2010-06-01 | — | — | US | disclosed |
| WO-2010038956-A2 | NOVEL AROMATIC DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | DAEJOO ELECTRONIC MATERIALS CO., LTD. (KR) | 2010-04-08 | — | — | WO | disclosed |
| EP-1848428-A2 | THIAZOLE AMIDES, IMIDAZOLE AMIDES AND RELATED ANALOGUES | NEUROGEN CORPORATION (US) | 2007-10-31 | — | — | EP | disclosed |
| WO-2006089076-A9 | THIAZOLE AMIDES, IMIDAZOLE AMIDES AND RELATED ANALOGUES | NEUROGEN CORP (US) | 2007-04-26 | — | — | WO | disclosed |
| WO-2006089076-A2 | THIAZOLE AMIDES, IMIDAZOLE AMIDES AND RELATED ANALOGUES | NEUROGEN CORPORATION (US) | 2006-08-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110049477-A1 | ELECTROACTIVE MATERIALS | KCNN4, KCNN3, HCN3 | ALDH1A1 3655/4885CYP2A6 3599/4885CYP1A2 2602/4885 |
| US-11891361-B2 | Heterocyclic compound and organic light emitting device comprising same | CRY1, CYP1A1, CYP1B1 | ALDH1A1 8/4885CYP2A6 80/4885CYP1A2 5/4885 |
| US-20230242484-A1 | NITROGEN-CONTAINING COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC APPARATUS USING SAME | MNS1, NSFL1C, NCF1 | ALDH1A1 1218/4885CYP2A6 3607/4885CYP1A2 2610/4885 |
| US-20100297035-A1 | Thiazole Amides, Imidazole Amides and Related Analogues | HRH3, HRH4, HRH2 | ALDH1A1 916/4885CYP2A6 2065/4885CYP1A2 1326/4885 |
| US-20110095273-A1 | DEUTERATED COMPOUNDS FOR LUMINESCENT APPLICATIONS | HDHD5, DDT, DLD | ALDH1A1 1218/4885CYP2A6 2214/4885CYP1A2 2400/4885 |
| US-20240090327-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | OR10J3, L1CAM, EPCAM | ALDH1A1 489/4885CYP2A6 2640/4885CYP1A2 1425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.